China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on rhTPO for ADC-Induced Thrombocytopenia in Solid Tumors'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130622
Registration Time: 2026/08/21
Type: Interventional study
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338738
Published by HT Digital Content Services with permission from Health Daily Digest....